Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Open-Label Randomized Controlled Study of Ciprofloxacin vs Rifaximin as Neutropenia Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation.
Gavriilaki E, Mallouri D, Laspa E, Papakonstantinou A, Lazaridou A, Varelas C, Baldoumi E, Giannakopoulou A, Demosthenous C, Vardi A, Bousiou Z, Batsis I, Gkioula G, Anagnostopoulos A, Sakellari I. Gavriilaki E, et al. Among authors: vardi a. Transplant Proc. 2024 Mar;56(2):380-385. doi: 10.1016/j.transproceed.2023.12.010. Epub 2024 Feb 16. Transplant Proc. 2024. PMID: 38368126 Free article. Clinical Trial.
Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
Gavriilaki E, Sakellari I, Batsis I, Mallouri D, Bousiou Z, Vardi A, Yannaki E, Constantinou V, Tsompanakou A, Vadikoliou C, Kaloyannidis P, Bamihas G, Anagnostopoulos A. Gavriilaki E, et al. Among authors: vardi a. Clin Transplant. 2018 Sep;32(9):e13371. doi: 10.1111/ctr.13371. Epub 2018 Aug 20. Clin Transplant. 2018. PMID: 30080283
Survival Advantage of Treosulfan Plus Fludarabine Before Allogeneic Hematopoietic Cell Transplantation for Older or Comorbid Patients With Myeloid Malignancies.
Sakellari I, Gavriilaki E, Mallouri D, Batsis I, Varelas C, Tagara S, Bousiou Z, Papathanasiou M, Vardi A, Papalexandri A, Vadikoliou C, Athanasiadou A, Lalayanni C, Fylaktou A, Antoniadis K, Anagnostopoulos A. Sakellari I, et al. Among authors: vardi a. Transplant Cell Ther. 2021 Nov;27(11):916.e1-916.e6. doi: 10.1016/j.jtct.2021.07.020. Epub 2021 Jul 25. Transplant Cell Ther. 2021. PMID: 34320443 Free article.
Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-Disease.
Gavriilaki E, Sakellari I, Chatzikonstantinou T, Bousiou Z, Mallouri D, Masmanidou M, Vardi A, Koravou EE, Kika F, Touloumenidou T, Papalexandri A, Yannaki E, Batsis I, Anagnostopoulos A. Gavriilaki E, et al. Among authors: vardi a. Transplant Proc. 2021 Sep;53(7):2261-2266. doi: 10.1016/j.transproceed.2021.07.043. Epub 2021 Aug 18. Transplant Proc. 2021. PMID: 34417030
A non-interventional study of microcirculation dynamics in allogeneic hematopoietic cell transplantation survivors compared to controls: evidence of impaired microvascular response regardless of conventional cardiovascular risk factors.
Gavriilaki E, Anyfanti P, Sakellari I, Batsis I, Dolgyras P, Lazaridis A, Nikolaidou B, Koletsos N, Gavriilaki M, Zarifis I, Masmanidou M, Bousiou Z, Vardi A, Douma S, Anagnostopoulos A, Gkaliagkousi E. Gavriilaki E, et al. Among authors: vardi a. Bone Marrow Transplant. 2022 Jan;57(1):72-77. doi: 10.1038/s41409-021-01500-w. Epub 2021 Oct 13. Bone Marrow Transplant. 2022. PMID: 34645924
Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
Sakellari I, Gavriilaki E, Batsis I, Mallouri D, Panteliadou AK, Lazaridou A, Vardi A, Constantinou V, Yannaki E, Papalexandri A, Kaloyannidis P, Smias C, Anagnostopoulos A. Sakellari I, et al. Among authors: vardi a. J Clin Apher. 2018 Dec;33(6):654-660. doi: 10.1002/jca.21660. Epub 2018 Nov 5. J Clin Apher. 2018. PMID: 30394564
BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma.
Sakellari I, Gavriilaki E, Bouziana S, Constantinou V, Mallouri D, Vardi A, Marvaki A, Batsis I, Sotiropoulos D, Anagnostopoulos A. Sakellari I, et al. Among authors: vardi a. Bone Marrow Transplant. 2019 Jun;54(6):921-923. doi: 10.1038/s41409-018-0395-y. Epub 2018 Nov 8. Bone Marrow Transplant. 2019. PMID: 30410083 No abstract available.
Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality.
Sakellari I, Gavriilaki E, Papagiannopoulos S, Gavriilaki M, Batsis I, Mallouri D, Vardi A, Constantinou V, Masmanidou M, Yannaki E, Smias C, Geroukis T, Kazis D, Kimiskidis V, Anagnostopoulos A. Sakellari I, et al. Among authors: vardi a. J Neurol. 2019 Aug;266(8):1960-1972. doi: 10.1007/s00415-019-09372-3. Epub 2019 May 13. J Neurol. 2019. PMID: 31087160
Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease.
Gavriilaki E, Sakellari I, Karafoulidou I, Pasteli N, Batsis I, Mallouri D, Lazaridou A, Iskas M, Vardi A, Papalexandri A, Tsompanakou A, Papaemmanouil S, Ilias A, Anagnostopoulos A. Gavriilaki E, et al. Among authors: vardi a. Int J Hematol. 2019 Nov;110(5):529-532. doi: 10.1007/s12185-019-02750-7. Epub 2019 Oct 4. Int J Hematol. 2019. PMID: 31586304
269 results